Illumina Stock Performance
| ILMN Stock | USD 149.86 2.23 1.47% |
On a scale of 0 to 100, Illumina holds a performance score of 12. The company retains a Market Volatility (i.e., Beta) of 1.01, which attests to a somewhat significant risk relative to the market. Illumina returns are very sensitive to returns on the market. As the market goes up or down, Illumina is expected to follow. Please check Illumina's treynor ratio, as well as the relationship between the semi variance and day median price , to make a quick decision on whether Illumina's current trending patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Illumina are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent primary indicators, Illumina displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.47) | Five Day Return (2.71) | Year To Date Return 11.54 | Ten Year Return (0.03) | All Time Return 687.49 |
Last Split Factor 1028:1000 | Last Split Date 2024-06-25 |
1 | Why Illumina Is Up 6.5 percent After Advancing Grail Divestiture Plan And Whats Next | 01/06/2026 |
2 | Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025 | 01/13/2026 |
3 | Illumina Inc. Shares See Target Boost as Analysts See Potential 2026 Upside | 01/20/2026 |
4 | Newborn Screening Market Trends Analysis Report 2025-2033 Focus on Instruments and Reagents Assay Kits, Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-Based A... | 01/21/2026 |
5 | Why Illumina Is Up 5.9 percent After CMS Backs TruSight Oncology Comprehensive Reimbursement | 01/22/2026 |
6 | 4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leadin... | 01/23/2026 |
7 | Latest Global Spatial Biology Market SizeShare Worth USD 7.24 Billion by 2035 at a 19.23 percent CAGR Custom Market Insights | 01/27/2026 |
| Begin Period Cash Flow | 1 B | |
| Total Cashflows From Investing Activities | -178 M |
Illumina Relative Risk vs. Return Landscape
If you would invest 12,354 in Illumina on October 31, 2025 and sell it today you would earn a total of 2,632 from holding Illumina or generate 21.3% return on investment over 90 days. Illumina is currently generating 0.3386% in daily expected returns and assumes 2.097% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of stocks are less volatile than Illumina, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Illumina Target Price Odds to finish over Current Price
The tendency of Illumina Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 149.86 | 90 days | 149.86 | about 8.39 |
Based on a normal probability distribution, the odds of Illumina to move above the current price in 90 days from now is about 8.39 (This Illumina probability density function shows the probability of Illumina Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.01 . This usually indicates Illumina market returns are highly reactive to returns on the market. As the market goes up or down, Illumina is expected to follow. Additionally Illumina has an alpha of 0.6007, implying that it can generate a 0.6 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Illumina Price Density |
| Price |
Predictive Modules for Illumina
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Illumina. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Illumina Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Illumina is not an exception. The market had few large corrections towards the Illumina's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Illumina, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Illumina within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.60 | |
β | Beta against Dow Jones | 1.01 | |
σ | Overall volatility | 14.18 | |
Ir | Information ratio | 0.16 |
Illumina Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Illumina for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Illumina can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Illumina currently holds 2.62 B in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Illumina has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Illumina's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 4.37 B. Net Loss for the year was (1.22 B) with profit before overhead, payroll, taxes, and interest of 2.93 B. | |
| Over 100.0% of Illumina shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Latest Global Spatial Biology Market SizeShare Worth USD 7.24 Billion by 2035 at a 19.23 percent CAGR Custom Market Insights |
Illumina Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Illumina Stock often depends not only on the future outlook of the current and potential Illumina's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Illumina's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 159 M | |
| Cash And Short Term Investments | 1.2 B |
Illumina Fundamentals Growth
Illumina Stock prices reflect investors' perceptions of the future prospects and financial health of Illumina, and Illumina fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Illumina Stock performance.
| Return On Equity | 0.31 | ||||
| Return On Asset | 0.0915 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 24.54 B | ||||
| Shares Outstanding | 152.8 M | ||||
| Price To Earning | 49.12 X | ||||
| Price To Book | 9.76 X | ||||
| Price To Sales | 5.37 X | ||||
| Revenue | 4.37 B | ||||
| Gross Profit | 2.93 B | ||||
| EBITDA | (725 M) | ||||
| Net Income | (1.22 B) | ||||
| Cash And Equivalents | 1.13 B | ||||
| Cash Per Share | 6.62 X | ||||
| Total Debt | 2.62 B | ||||
| Debt To Equity | 0.38 % | ||||
| Current Ratio | 0.93 X | ||||
| Book Value Per Share | 15.56 X | ||||
| Cash Flow From Operations | 837 M | ||||
| Earnings Per Share | 4.46 X | ||||
| Market Capitalization | 23.03 B | ||||
| Total Asset | 6.3 B | ||||
| Retained Earnings | (1.24 B) | ||||
| Working Capital | 1.2 B | ||||
| Current Asset | 2.1 B | ||||
| Current Liabilities | 610.49 M | ||||
About Illumina Performance
By examining Illumina's fundamental ratios, stakeholders can obtain critical insights into Illumina's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Illumina is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 140.00 | 173.86 | |
| Return On Tangible Assets | (0.23) | (0.22) | |
| Return On Capital Employed | (0.13) | (0.11) | |
| Return On Assets | (0.10) | (0.10) | |
| Return On Equity | (0.18) | (0.17) |
Things to note about Illumina performance evaluation
Checking the ongoing alerts about Illumina for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Illumina help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Illumina currently holds 2.62 B in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Illumina has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Illumina's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 4.37 B. Net Loss for the year was (1.22 B) with profit before overhead, payroll, taxes, and interest of 2.93 B. | |
| Over 100.0% of Illumina shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Latest Global Spatial Biology Market SizeShare Worth USD 7.24 Billion by 2035 at a 19.23 percent CAGR Custom Market Insights |
- Analyzing Illumina's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Illumina's stock is overvalued or undervalued compared to its peers.
- Examining Illumina's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Illumina's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Illumina's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Illumina's stock. These opinions can provide insight into Illumina's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Will Life Sciences Tools & Services sector continue expanding? Could Illumina diversify its offerings? Factors like these will boost the valuation of Illumina. Market participants price Illumina higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Illumina data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.78) | Earnings Share 4.46 | Revenue Per Share | Quarterly Revenue Growth 0.004 | Return On Assets |
Illumina's market price often diverges from its book value, the accounting figure shown on Illumina's balance sheet. Smart investors calculate Illumina's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Illumina's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.